FTXH First Trust Nasdaq Pharmaceuticals ETF Stock Quote

FTXH [NASD]

First Trust Nasdaq Pharmaceuticals ETF

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	-	Perf Week	1.68%
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-0.28%
Income	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-2.34%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	8.17%
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Target Price	-	Perf Year	19.97%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	21.32 - 27.16	Perf YTD	1.58%
Dividend	0.23	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-3.62%	Beta	-
Dividend %	0.88%	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	22.78%	ATR	0.32
Employees	-	Current Ratio	-	Sales Q/Q	-	Oper. Margin	-	RSI (14)	59.03	Volatility	0.73% 1.01%
Optionable	No	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.16	Prev Close	25.83
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	12.21K	Price	26.18
Recom	-	SMA20	2.48%	SMA50	0.95%	SMA200	4.46%	Volume	1,907	Change	1.33%

Nov-11-20 08:00AM	Ways To Make Money From Pfizer's Miracle Vaccine Investor's Business Daily
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings Zacks
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings Zacks
Sep-24-19 05:27PM	First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds Business Wire
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? Zacks
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results Zacks
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday Zacks
Feb-28-19 04:43PM	Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results ETF Trends
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results Zacks
Jan-23-19 02:04PM	Healthcare ETFs Slip After Abbot Labs Revenue Miss, Weak Outlook ETF Trends
Oct-24-18 11:59AM	ETF Strategies for the Midterm Elections Zacks
Oct-12-18 06:00AM	Top 5 Pharmaceutical ETFs for 2018 Investopedia
Jan-26-18 09:02AM	Pfizers 4Q17 Estimates: Products with Lower Sales Market Realist
Jan-12-18 07:31AM	Wall Street Recommendations for Mylan in January 2018 Market Realist
Jan-01-18 07:33AM	Eli Lillys New Products Portfolio in 3Q17 Market Realist
Sep-12-17 10:36AM	Behind Mercks Animal Health Segment Performance in 2Q17 Market Realist
Sep-04-17 09:06AM	What to Expect from Pfizers Biosimilars Business Market Realist
Sep-01-17 07:38AM	Performance of Eli Lillys Business Segments in 2Q17 Market Realist
Aug-30-17 09:07AM	Major Developments for Johnson & Johnson in 2Q17 Market Realist
Aug-11-17 03:59PM	Pfizers Valuation after 2Q17 Earnings Market Realist
May-05-17 09:59AM	Trump Wins Healthcare Vote: ETFs to Watch Zacks
Mar-22-17 05:25PM	First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds Business Wire
Dec-09-16 09:36AM	Johnson & Johnsons Revenue Trend in 3Q16 Market Realist
Oct-25-16 03:04PM	Bristol-Myers Squibbs 3Q16 Estimates: Oncology Segment Market Realist
Oct-20-16 08:07AM	The Nasdaq Stock Market® Captures 35 Percent of U.S. ETP Listings and Switches in the Third Quarter of 2016 GlobeNewswire
Oct-14-16 12:04PM	Good News: Johnson & Johnsons 3Q16 Revenues Expected to Rise Market Realist
Sep-28-16 09:00AM	This Weeks ETF Launches: First Trust Tries Its Hands at Sectors ETF Database
Sep-27-16 09:00AM	This Weeks ETF Launches: First Trust Tries Its Hands at Sectors
Sep-22-16 01:55PM	7 First Trust Smart Sector ETFs to Diversify, Manage Risk ETF Trends
Sep-21-16 09:12AM	First Trust Launches Seven ETFs Based on Nasdaq US Smart Sector IndexesSM Business Wire

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.

open in yahoo | open in marketwatch | open in google

Upgrade your FINVIZ experience